Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,908.00    -5.00 (-0.26%)
Bid:
1,906.50
Ask:
1,907.50
Spread: 1.00 (0.052%)
Market Cap: £76.52b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

UK stocks end slightly higher after inflation data; focus on Fed, BoE meetings
18 Jun 2025

UK stocks end slightly higher after inflation data; focus on Fed, BoE meetings

FTSE 100 gains 0.1%, FTSE 250 adds 0.3% *

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of Fed after in line CPI
18 Jun 2025

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of Fed after in line CPI

(Alliance News) - London's FTSE 100 posted modest gains on Wednesday amid ongoing Middle East tensions, as investors weighed broadly in line UK inflat...

DIRECTOR DEALINGS: New B&M CEO Tjeerd Jegen buys GBP500,000 in shares
17 Jun 2025

DIRECTOR DEALINGS: New B&M CEO Tjeerd Jegen buys GBP500,000 in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past several days and...

LONDON MARKET CLOSE: Stocks up on hopes of thaw to Middle East tension
16 Jun 2025

LONDON MARKET CLOSE: Stocks up on hopes of thaw to Middle East tension

(Alliance News) - The FTSE 100 ended higher on Monday, just shy of a record closing high, on reports Iran is willing to resume nuclear talks with the ...

LONDON MARKET CLOSE: Stocks slide, oil jumps after Israel strikes Iran
13 Jun 2025

LONDON MARKET CLOSE: Stocks slide, oil jumps after Israel strikes Iran

(Alliance News) - The oil price soared and stocks slumped on Friday after Israel launched dozens of air strikes against Iran, ramping up tensions in t...

GSK applies to EU regulator for expanded use of RSV vaccine
13 Jun 2025

GSK applies to EU regulator for expanded use of RSV vaccine

GSK seeks EU approval for RSV vaccine for younger adults *

GSK's RSV drug Arexvy accepted for regulatory review in Europe
13 Jun 2025

GSK's RSV drug Arexvy accepted for regulatory review in Europe

(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has been accepted for regulatory review by the European Medi...

CORRECT: PHP hits back after Assura backs KKR offer
13 Jun 2025

CORRECT: PHP hits back after Assura backs KKR offer

(Correcting currency of bid for Adriatic Metals.)